A dose-escalation and safety gene therapy study in a model of CMT4C neuropathy

by Biotech Newsroom


  • Senderek J, Bergmann C, Stendel C, Kirfel J, Verpoorten N, De Jonghe P, et al. Mutations in a gene encoding a novel SH3/TPR domain protein cause autosomal recessive Charcot-Marie-Tooth type 4C neuropathy. Am J Hum Genet. 2003;73:1106–19.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Sun B, He ZQ, Li YR, Bai JM, Wang HR, Wang HF, et al. Screening for SH3TC2 variants in Charcot-Marie-Tooth disease in a cohort of Chinese patients. Acta Neurol Belg. 2022;122:1169–75.

    Article 
    Source link

  • You may also like

    Houston, TX – (EmailWire) — The Biotech Times™ aggregates, publishes and distributes news about the Biotech Industry. In association with EmailWire™, The Biotech Times, helps businesses and organizations in the industry with press release distribution. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

    Free Magazines

    Recent Articles

    BioTech Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC